We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
AI-based music generation platform SoulChord takes the crown at this year's Student Entrepreneurship Programme.
From supermarket peas to multi million-dollar deals: Oxford's biotech startups are rewriting the playbook on chronic inflammation, genomic mysteries, and the AI in medicine. Witness how audacious ideas, nurtured in humble settings, mature into world-changing medical innovations in an ecosystem where science, business, and global impact entwine.
Funding via the Connecting Capability Fund will provide acceleration of support for the UK university social venture sector.
Caristo's Frank Cheng speaks with OUI on transforming heart disease diagnostics, the evolution of Oxford, and the future of one of Oxford's most exciting companies.
Dr Liisa Chisty joins Oxford University Innovation's Clinical Outcomes Team, reinforcing their commitment to patient-centric care and licensing Clinical Outcome Assessments (COAs).
Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.
Take a glimpse into the future with startups emerging from OUI’s incubator.
